VEGFA and neoplasm: The miR-200 family is well known to inhibit epithelial-mesenchymal transition and tumor metastasis [38]; miR-200b is cited as negative regulator of VEGF expression and angiogenesis in lung adenocarcinoma [39], but its effect on human chondrosarcoma is largely unknown.